[1] Wang DY, Hao YL, Xiao M, et al. Epidemiology and etiology of multiple myeloma[J]. Internation Journal of Epidemilogy and Infectious Disease, 2018,45(4):277-280.(in Chinese)
王得印, 郝云良, 肖萌, 等. 多发性骨髓瘤流行病学及病因分析[J]. 国际流行病学传染病学杂志, 2018,45(4):277-280.
[2] Chinese Hematology Association, Chinese Society of Hematology, Chinese Myeloma Committee-Chinese Hematology Associatio. The guidelines for the diagnosis and management of multiple myeloma in China(2017 revision)[J]. Chinese Journal of Internal Medicine, 2017,56(11):866-870.(in Chinese)
中国医师协会血液科医师分会, 中华医学会血液学分会, 中国医师协会多发性骨髓瘤专业委员会. 中国多发性骨髓瘤诊治指南(2017年修订)[J]. 中华内科杂志, 2017,56(11):866-870.
[3] Pfeffer SR. Rab GTPases: master regulators that establish the secretory and endocytic pathways[J]. Mol Biol Cell, 2017,28(6):712-715.
[4] Liu T. Mir-139-3p function as tumor suppressor in colorectal cancer by targeting RAb1A[D]. Suzhou: Suzhou University, 2017.(in Chinese)
刘涛. MiR-139-3p靶向调控RAb1A表达对结直肠癌的影响[D]. 苏州: 苏州大学, 2017.
[5] Yang B, Zhao S. Polydatin regulates proliferation, apoptosis and autophagy in multiple myeloma cells through mTOR/p70s6k pathway[J]. Oncotargets Ther, 2017, 10:935-944.
[6] Liu H, Wang H, Wu B, et al. Down-regulation of long noncoding RNA MALAT1 by RNA interference inhibits proliferation and induces apoptosis in multiple myeloma[J]. Clin Exp Pharmacol Physiol, 2017,44(10):1032-1041.
[7] Cheng ZhW, Wang ZK. Research advances of Rab1A in the development of cancer[J]. Journal of Medical Postgraduates, 2018,31(1):73-76.(in Chinese)
程正武, 王子康. Rab1A与肿瘤发生发展的研究进展[J]. 医学研究生学报, 2018,31(1):73-76.
[8] Quan Y, Song Q, Wang J, et al. MiR-1202 functions as a tumor suppressor in glioma cells by targeting Rab1A[J]. Tumour Biol, 2017,39(4):1010428317697565.
[9] Xu B, Huang C, Yang X, et al. Significance and prognostic role of human epidermal growth factor receptor 2 and RAB1A expression in gastric cancer[J]. Oncol Lett, 2018, 15(4):5185-5192.
[10] Xu H, Xu H, Qian M, et al. Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells[J]. Oncol Rep, 2017, 37(3):1619-1626.
[11] Duan Zh, Gong PJ, Du J, et al. Effects of RablA siRNA on proliferation and apoptosis of cervical cancer HeLa cell line and its molecular mechanism[J]. Journal of Shanxi Medical University, 2016,47(4):319324.(in Chinese)
段钊, 公丕军, 杜娟, 等. Rab1A siRNA对宫颈癌HeLa细胞增殖和凋亡的影响及其分子机制[J]. 山西医科大学学报, 2016,47(4):319-324.
[12] Thomas JD, Zhang YJ, Wei YH, et al. Rab1A is an mTORC1 activator and a colorectal oncogene[J]. Cancer Cell, 2014,26(5):754-769.
[13] Liu P, Ge M, Hu J, et al. A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis[J]. Hepatology, 2017, 66(1):167-181.
[14] Ge SX.The role of mTORC1/c-myc loop in the development of breast cancer[D]. Hefei: Anhui Medical University, 2018.(in Chinese)
葛素侠. mTORC1/c-0myc环路在乳腺癌发生发展中的作用研究[D]. 合肥:安徽医科大学, 2018.
[15] Cianciulli A, Porro C, Calvello R, et al. Resistance to apoptosis in Leishmania infantum -infected human macrophages: a critical role for anti-apoptotic Bcl-2 protein and cellular IAP1/2[J]. Clin Exp Med, 2017, 18(2):1-11.
[16] Xu Z, Zheng M, Li Z, et al. Effect of ATP and Bax on the apoptosis of Eimeria tenella host cells[J]. Bmc Vet Res, 2017, 13(1):399.
[17] Wang YB, Zhao XH, Li G, et al. MicroRNA-184 inhibits proliferation and promotes apoptosis of human colon cancer SW480 and HCT116 Cells by downregulating C-MYC and BCL-2[J]. J Cell Biochem, 2017,119(2):1702-1715.
[18] Liang J, Cao R, Wang X, et al. Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl-2[J]. Cell Res, 2017, 27(3):329-351.
[19] Zhu L, Hao J, Cheng M, et al. Hyperglycemia-induced Bcl-2/Bax-mediated apoptosis of Schwann cells via mTORC1/S6K1 inhibition in diabetic peripheral neuropathy[J]. Exp Cell Res, 2018,367(2):186-195.
[20] Zhang JF. The expression and clinical significance of Rab1A and RAB31 in hepatocellular carcinoma [D]. Ji’nan: Zhengzhou University, 2018.(in Chinese)
张劲夫. Rab1A、Rab31在肝细胞肝癌中的表达与临床意义[D]. 济南: 郑州大学, 2018.
|